MimiVax
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Elm and Carlton St, Buffalo, New York, 1...Phone Number
(716) 845-8850Website
www.mimivax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About MimiVax
MimiVax is a clinical-stage biotechnology company focused on developing innovative immunotherapies to disrupt cancer, particularly through its lead product, SurVaxM. The company aims to improve survival rates for patients suffering from glioblastoma and other cancers by conducting clinical trials and advancing its research pipeline. MimiVax is dedicated to enhancing the quality of life for cancer patients and is actively involved in partnerships to strengthen the biomedical ecosystem in Buffalo, New York. Their mission is to provide hope and better treatment outcomes for those affected by devastating diseases.Explore more
MimiVax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MimiVax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if MimiVax has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on MimiVax recently announced quarterly report
Website visits: Recent activity has been detected on your website
MimiVax, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once MimiVax has new funding data
Product Launch: Get notified when MimiVax launches new products
Congratulate Masked Content for being promoted to Masked Content at MimiVax
Click to see if MimiVax had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if MimiVax is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined MimiVax as Masked Content
Find more new buyers
Compare Similar Companies to MimiVax
Compare insights from companies similar to MimiVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MimiVax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MimiVax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MimiVax.
MimiVax financials insights
Gather financial insights about MimiVax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$1.6M
MimiVax Tech Stack
A closer look at the technologies used by MimiVax
See more technologies
MimiVax News & Media
MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment
SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facility UI Pharmaceuticals is looking forward to supporting the need for larger clinical and commercial lots MimiVax is utilizing SurVaxM in a Randomized Phase 2b clinical trial of glioblastoma BUFFALO, N.Y., Jan....Biotech firm raises $5.8M for cancer drug trial - Buffalo - WGRZ-TV
Buffalo-based MimiVax has raised millions as it works toward commercialization of its cancer immunotherapy drug.MimiVax Raises Funding
MimiVax, a NYC-based biotechnology company focused on the development of SurVaxM, a survivin-targeted vaccine therapy for glioblastoma and other cancers, raised an undisclosed amount in funding. The round saw participation from Brain Tumor Investment Fund, an affiliate of the National Brain Tumor Society (NBTS), the Sontag Innovation Fund, a subsidiary of the Sontag Foundation, the MEDA Angels, LLC, Varia Ventures and private […] The post MimiVax Raises Funding appeared first on FinSMEs.MimiVax Granted Fast Track Designation from FDA for SurVaxM for Newly Diagnosed Glioblastoma
BUFFALO, N.Y., Oct. 12, 2023 /PRNewswire/ -- MimiVax, Inc., a biotechnology company focused on the development of glioblastoma vaccine therapy, announced today that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to MimiVax's SurVaxM vaccine...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding MimiVax
Sign Up For FreeTo access detailed company insights
MimiVax is a clinical-stage biotechnology company focused on developing innovative immunotherapies to disrupt cancer, particularly through its lead product, SurVaxM. The company aims to improve survival rates for patients suffering from glioblastoma and other cancers by conducting clinical trials and advancing its research pipeline. MimiVax is dedi... Read More
